I agree that this site is using cookies. You can find further informations here.
X
Dhalwani, N.
116  results:
Search for persons X
?
1

Characteristics of patients initiating PCSK9i mAb following..:

Chan, Q ; Wouter Jukema, J ; Heintjes, E M...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

Evolocumab use in Greece is associated with early and susta..:

Vlachopoulos, C. ; Massia, D. ; Kochiadakis, G....
Hellenic Journal of Cardiology.  74 (2023)  - p. 74-76 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Recurrent atherosclerotic cardiovascular disease events pre..:

Sakhuja, S ; Bittner, V A ; Brown, T M...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

Evolocumab treatment is associated with early and sustained..:

Ray, K K ; Perrone-Filardi, P ; Ebenbichler, C...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
5

Final results from the pan-European observational heymans s..:

Ray, K.K. ; Bruckert, E. ; Perrone-Filardi, P....
Atherosclerosis.  355 (2022)  - p. 14 , 2022
Link: https://doi.org/10.1016/..
 
?
6

High long-term persistence to evolocumab treatment regimens..:

Ray, K K ; Perrone-Filardi, P ; Ebenbichler, C...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
7

Potential cardiovascular risk reduction with evolocumab in ..:

Ray, K ; Bridges, I ; Bruckert, E...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
8

Evolocumab use and LDL-C lowering in a cohort of European p..:

Sibartie, M. ; Dhalwani, N. ; Ebenbichler, C...
Atherosclerosis.  331 (2021)  - p. e21 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Evolocumab use in Europe: clinical guidelines vs. reimburse..:

Ray, K K ; Bruckert, E ; Filardi, P...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
10

Evolocumab use and LDL-C lowering in a cohort of european p..:

Sibartie, M. ; Dhalwani, N. ; Bridges, I....
Atherosclerosis.  331 (2021)  - p. e253 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Leisure‐time physical activity and life expectancy in peopl..:

Chudasama, Y. V. ; Zaccardi, F. ; Gillies, C. L....
Journal of Internal Medicine.  287 (2019)  1 - p. 87-99 , 2019
Link: https://doi.org/10.1111/..
 
?
12

Educational weight loss interventions in obese and overweig..:

Maula, A. ; Kai, J. ; Woolley, A. K....
Diabetic Medicine.  37 (2019)  4 - p. 623-635 , 2019
Link: https://doi.org/10.1111/..
 
?
13

Body mass index and mortality in people with and without di..:

Dhalwani, N.N. ; Zaccardi, F. ; Davies, M.J..
Nutrition, Metabolism and Cardiovascular Diseases.  28 (2018)  12 - p. 1208-1216 , 2018
Link: https://doi.org/10.1016/..
 
?
14

PRM84 - LEVERAGING HOSPITAL-BASED EMR SYSTEMS FOR REAL-WORL..:

Stein, D ; Carroll, R ; Dhalwani, N.
Value in Health.  21 (2018)  - p. S369-S370 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Non-invasive liver tests in electronic health records of pa..:

Dhalwani, N. ; Alexander, M. ; Loomis, K....
Journal of Hepatology.  68 (2018)  - p. S551-S552 , 2018
Link: https://doi.org/10.1016/..
 
1-15